Omni Bridgeway (OBL) AGM 2026 presentation summary

FY26 financial and operating performance

• Statutory NPAT was A$45.9m; FY25's A$416.8m included a one-off Fund 9 transaction gain. Fee income rose 17% to A$35.4m and cash opex fell 20% to A$67.1m.

• FY26 statutory total income was A$182.2m, NPBT A$48.2m, return on equity 8.0% and EPS A$0.19; book value was A$2.96 per share, down 1% YoY.

• Fee-income cost coverage increased from 36% to 53% in FY26, versus 17% three years earlier; cash opex was 16% below the FY26 budget.

Portfolio performance and capital formation

• FY26 investment proceeds were A$350.5m, up 49% YoY excluding the Fund 9 transaction; 80 full and partial completions achieved 2.3x MOIC and 105% fair value conversion.

• New commitments reached a record A$712.2m across 43 new investments, up 38% YoY, adding A$564.4m in new portfolio fair value.

• AUM rose 12% YoY to A$5.9bn across 11 funds; the Funds 4/5 Series II raise closed at its US$1bn target, with a 99% Series I reinvestment rate.

• 1QFY27 proceeds were A$135.8m versus A$136.6m in 1QFY26; fee income was A$10.7m, up 24%, and the pipeline reached A$416.6m versus A$317.8m.

• 1QFY27 completions achieved 3.9x MOIC; 46 exclusive term sheets represented estimated commitments of A$416.6m if contracted.

Strategic execution and growth

• Fund 9 enabled full debt repayment, reduced balance-sheet exposure through fund deconsolidation and validated the fair value framework; the shift to a capital-light asset-management model is largely complete.

• Phase 1 restructuring included repaying A$250m debt, eliminating A$30m of annual interest expense and settling the final A$28m legacy balance-sheet liability.

• FY26 capital formation exceeded A$1.6bn across fund and sidecar capital; the US$1bn Series II fund raise closed at target.

• Growth plans include expanding existing strategies and adding geographies, areas of law and investment types, including legal credit, legal insurance and structured finance.